aging

In the Lab Megan Molteni

Eggs can survive decades without signs of aging. Now, scientists may know why

Special Report Eric Boodman

In the label ‘adult failure to thrive,’ medicine reveals its own failures

First Opinion Podcast Patrick Skerrett

Listen: Covid turned the nation’s eyes to nursing homes. Have we already looked away?

First Opinion David C. Grabowski, Marilyn Rantz and Jasmine L. Travers

Report: U.S. nursing home care is ineffective, inefficient, inequitable, fragmented, and unsustainable

In the Lab Megan Molteni

In the blood of marathoning mice, scientists find clues to how exercise benefits the brain

First Opinion Eilon Caspi

Resident-to-resident incidents are a hidden source of harm in nursing homes. They shouldn’t be

Health Elizabeth Cooney

The ‘active grandparent hypothesis’: New research explores how we’ve evolved to move more and live longer

Biotech Megan Molteni

Anti-aging research foundation stands by ouster of Aubrey de Grey after investigation concludes

Biotech Megan Molteni

Scientist Aubrey de Grey made inappropriate sexual comments to two female entrepreneurs, independent investigation finds

First Opinion Aytan Y. Bellin

My aunt’s ‘Kafkaesque journey’ to get the home care she needs

Biotech Megan Molteni

SENS Research Foundation removes Aubrey de Grey over concerns he was interfering in sexual harassment investigation

First Opinion Podcast Patrick Skerrett

Listen: An ENT physician & an advocate on the high monetary and social costs of hearing loss

Exclusive Megan Molteni

Anti-aging foundation’s CEO left amid an investigation of co-founder Aubrey de Grey

Health Alicia Diaz

The decision to pull loved ones out of nursing homes when the pandemic hit was a great alternative — for those who could afford it 

First Opinion Laura Fraade-Blanar, Ryan Best and Vijeth Iyengar

Ridesharing can help older people be functionally independent in their homes, communities

First Opinion Frank R. Lin, Charlotte Yeh and Christine Cassel

Making hearing aids affordable isn’t enough. Older adults also need hearing care services

Health Jonathan Saltzman — Boston Globe

Retired neurologist with Alzheimer’s knows firsthand the risks of Aduhelm

First Opinion Jason Resendez and Stephanie Monroe

Clinical research doesn’t reflect the Alzheimer’s population. That needs to change

First Opinion Andrew C. von Eschenbach

With Aduhelm, history can repeat itself by following cancer’s success

First Opinion Madhav Thambisetty

‘When Memory Fades’: Misinformation about Alzheimer’s disease and Aduhelm must be limited

STAT Summit Elizabeth Cooney

‘Aduhelm left room’: Lilly CEO eyes competition with Biogen Alzheimer’s drug

Biotech Adam Feuerstein

FDA, under fire from critics, revises prescribing information for Biogen’s Alzheimer’s drug

First Opinion Emil D. Kakkis

Aduhelm’s accelerated approval offers a promising roadmap for rare neurological diseases

First Opinion Josh Marx

Outdated Medicare rules threaten older Americans’ access to home medical equipment

Pharmalot Ed Silverman

Revised analysis nudges up cost-effective price for Biogen’s Alzheimer’s drug to $3,000 to $8,400 a year